This study compares adding AZD6738 to durvalumab versus durvalumab alone, following treatment with chemotherapy and surgery, in the treatment of patients with non-small cell lung cancer.
Contact phone
(517) 364-2835
Contact email
[email protected]
Principal investigator
Dr. Srkalovic, MD, PhD
Trial Category
Cancer
Trial SubCategory
Non-Small Cell Lung
Webform